rs574132670
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_005957.5(MTHFR):c.548G>A(p.Arg183Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,614,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000039 ( 0 hom. )
Consequence
MTHFR
NM_005957.5 missense
NM_005957.5 missense
Scores
12
5
2
Clinical Significance
Conservation
PhyloP100: 7.26
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_005957.5
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.937
PP5
Variant 1-11800250-C-T is Pathogenic according to our data. Variant chr1-11800250-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 187876.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTHFR | NM_005957.5 | c.548G>A | p.Arg183Gln | missense_variant | 4/12 | ENST00000376590.9 | NP_005948.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTHFR | ENST00000376590.9 | c.548G>A | p.Arg183Gln | missense_variant | 4/12 | 1 | NM_005957.5 | ENSP00000365775.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
4
AN:
152180
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000596 AC: 15AN: 251492Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135920
GnomAD3 exomes
AF:
AC:
15
AN:
251492
Hom.:
AF XY:
AC XY:
10
AN XY:
135920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 727242
GnomAD4 exome
AF:
AC:
57
AN:
1461868
Hom.:
Cov.:
31
AF XY:
AC XY:
41
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152298Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74464
GnomAD4 genome
AF:
AC:
4
AN:
152298
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Homocystinuria due to methylene tetrahydrofolate reductase deficiency Pathogenic:4
Pathogenic, no assertion criteria provided | clinical testing | University Children's Hospital, University of Zurich | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Aug 24, 2020 | A heterozygous missense variation in exon 3 of the MTHFR gene that results in the amino acid substitution of Glutamine for Arginine at codon 183 was detected. The observed variant c.548G>A (p.Arg183Gln) lies in the methylenetetrahydrofolate reductase domain of the MTHFR protein and has previously been reported in homozygous state, in patients affected with homocystinuria (Burda et al. 2015). Functional studies showed that the observed missense caused deleterious loss of MTHFR protein expression and activity (Burda et al. 2017). The variant has a minor allele frequency of 0.02% in the 1000 genomes and 0.006% in gnomAD database. The in silico predictions of the variant are probably damaging by PolyPhen-2 (HumDiv) and damaging by SIFT, LRT and MutationTaster2. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 183 of the MTHFR protein (p.Arg183Gln). This variant is present in population databases (rs574132670, gnomAD 0.03%). This missense change has been observed in individual(s) with MTHFR deficiency (PMID: 25736335). ClinVar contains an entry for this variant (Variation ID: 187876). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MTHFR protein function. Experimental studies have shown that this missense change affects MTHFR function (PMID: 27743313). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | MTHFR: PM2, PP1:Moderate, PM3:Supporting, PS3:Supporting - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 12, 2020 | Published functional studies demonstrate a damaging effect (residual enzyme activity in fibroblasts ranging from 20-22%) (Burda et al., 2015); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 26872964, 25736335, 27743313) - |
Thrombophilia due to thrombin defect Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | Jun 22, 2023 | The observed missense c.548G>A (p.Arg183Gln) variant in MTHFR gene has been reported in heterozygous/ homozygous states in multiple individuals affected with MTHFR-related disorders (Burda et al., 2015; Capalbo et al., 2019; Froese et al., 2016). Functional studies showed that the variant caused deleterious loss of MTHFR protein expression and activity (Burda et al., 2017). This variant is present with allele frequency of 0.006% in gnomAD Exomes. This variant has been reported to the ClinVar database as Likely Pathogenic/ Pathogenic. Multiple lines of computational evidence (Polyphen - Probably Damaging, SIFT - Damaging and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. The reference amino acid of p.Arg183Gln in MTHFR is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 183 is changed to a Gln changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. - |
Neural tube defects, folate-sensitive Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 22, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;.;.;D;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D;.;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;.;.;M;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;.;.;.
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D;.;.;.
Sift4G
Uncertain
D;D;D;D;.;.;.
Polyphen
D;.;.;D;.;.;.
Vest4
MutPred
Loss of ubiquitination at K180 (P = 0.0613);.;.;Loss of ubiquitination at K180 (P = 0.0613);.;Loss of ubiquitination at K180 (P = 0.0613);Loss of ubiquitination at K180 (P = 0.0613);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at